AGP-3 Inhibitors
Chemical inhibitors of AGP-3 function through various cellular pathways by targeting specific enzymes and kinases that are upstream or part of the signaling cascades essential for AGP-3 activity. For instance, Wortmannin and LY294002 are inhibitors of phosphoinositide 3-kinases (PI3K). PI3K is critical for the activation of several downstream proteins, including AGP-3. By inhibiting PI3K, these chemicals prevent the formation of phosphatidylinositol (3,4,5)-trisphosphate, a necessary secondary messenger for AGP-3 activation. Rapamycin targets the mTOR pathway, which is a central regulator of cell growth and proliferation. If AGP-3 relies on mTOR signaling for its function, rapamycin can inhibit AGP-3 by disrupting the protein synthesis and autophagy processes that mTOR controls. Similarly, SB203580 and PD98059 inhibit the p38 MAP kinase and MEK, respectively. These kinases are part of the MAPK pathway, which is often implicated in the regulation of protein function. By inhibiting these kinases, SB203580 and PD98059 prevent the necessary phosphorylation events that would typically lead to AGP-3 activation.
Furthermore, U0126, a selective inhibitor of both MEK1 and MEK2, and SP600125, an inhibitor of JNK, also disrupt the MAPK signaling pathway, thereby preventing the activation of AGP-3. Triciribine directly inhibits Akt, a kinase that is involved in numerous cellular processes. If AGP-3 functions downstream of Akt, the inhibition of Akt by triciribine would result in the suppression of AGP-3 activity. Stattic works by inhibiting the activation and dimerization of STAT3, a transcription factor. If AGP-3 activity is regulated by STAT3, Stattic would inhibit AGP-3 by preventing the necessary transcriptional activity. NSC 23766 targets Rac1, a GTPase that, when inhibited, would disrupt Rac1-dependent signaling pathways crucial for AGP-3. BAY 11-7082 inhibits NF-κB, a transcription factor that regulates the expression of various genes, including those required for AGP-3's function. By blocking the phosphorylation of IκBα, BAY 11-7082 prevents NF-κB from activating the genes necessary for AGP-3 activity. Lastly, CCG-1423 inhibits RhoA-mediated transcriptional signaling, which, if involved in the regulation of AGP-3, would result in the inhibition of AGP-3 due to the blockade of RhoA's gene transcription effects.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). If AGP-3 is downstream of PI3K signaling, wortmannin can lead to the functional inhibition of AGP-3 by preventing its activation through this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of PI3K. Similar to wortmannin, it can functionally inhibit AGP-3 if AGP-3 operates downstream of the PI3K pathway by blocking the formation of phosphatidylinositol (3,4,5)-trisphosphate and thus inhibiting the signaling required for AGP-3 activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin selectively inhibits mTOR (mechanistic target of rapamycin). If AGP-3 is regulated by mTOR signaling, rapamycin can inhibit the function of AGP-3 by disrupting this pathway, which is crucial for multiple cellular processes including protein synthesis and autophagy. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. If AGP-3 is activated by p38 MAPK pathway, SB203580 can inhibit AGP-3 by preventing its phosphorylation and subsequent activation through this specific signaling cascade. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which is upstream of ERK in the MAPK pathway. If AGP-3 is functionally dependent on the ERK/MAPK pathway, PD98059 can inhibit AGP-3 activity by blocking the necessary phosphorylation events that lead to AGP-3 activation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If AGP-3 operates within the JNK signaling pathway, SP600125 can inhibit AGP-3 by blocking JNK-mediated signaling processes, which may be necessary for AGP-3's function. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits Akt, also known as protein kinase B. If AGP-3 function is dependent on Akt signaling, triciribine can inhibit AGP-3 by blocking Akt activation and its downstream signaling, which could be critical for AGP-3 function. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Stattic selectively inhibits STAT3 activation and dimerization. If AGP-3's activity is modulated by STAT3-dependent signaling, Stattic can inhibit AGP-3 by preventing STAT3 phosphorylation and subsequent transcriptional activity required for AGP-3 function. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits Rac1 activation by preventing its interaction with guanine nucleotide exchange factors (GEFs). If AGP-3 is regulated by Rac1-dependent pathways, NSC 23766 can inhibit AGP-3 by blocking the activation of Rac1 and subsequent signaling events that could be necessary for AGP-3 function. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 irreversibly inhibits NF-κB activation by blocking the phosphorylation of IκBα. If AGP-3 is regulated by NF-κB signaling, BAY 11-7082 can inhibit AGP-3 by disrupting NF-κB's ability to translocate to the nucleus and mediate transcriptional responses that are essential for AGP-3's activity. | ||||||